Literature DB >> 16788713

Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics.

Evan D Morris1, Karmen K Yoder.   

Abstract

There is great interest in positron emission tomography (PET) as a noninvasive assay of fluctuations in synaptic neurotransmitter levels, but questions remain regarding the optimal choice of tracer for such a task. A mathematical method is proposed for predicting the utility of any PET tracer as a detector of changes in the concentration of an endogenous competitor via displacement of the tracer (a.k.a., its 'vulnerability' to competition). The method is based on earlier theoretical work by Endres and Carson and by the authors. A tracer-specific predictor, the PET Displacement Sensitivity (PDS), is calculated from compartmental model simulations of the uptake and retention of dopaminergic radiotracers in the presence of transient elevations of dopamine (DA). The PDS predicts the change in binding potential (DeltaBP) for a given change in receptor occupancy because of binding by the endogenous competitor. Simulations were performed using estimates of tracer kinetic parameters derived from the literature. For D(2)/D(3) tracers, the calculated PDS indices suggest a rank order for sensitivity to displacement by DA as follows: raclopride (highest sensitivity), followed by fallypride, FESP, FLB, NMSP, and epidepride (lowest). Although the PDS takes into account the affinity constant for the tracer at the binding site, its predictive value cannot be matched by either a single equilibrium constant, or by any one rate constant of the model. Values for DeltaBP have been derived from published studies that employed comparable displacement paradigms with amphetamine and a D(2)/D(3) tracer. The values are in good agreement with the PDS-predicted rank order of sensitivity to displacement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788713     DOI: 10.1038/sj.jcbfm.9600359

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  23 in total

1.  Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches.

Authors:  Karmen K Yoder; Daniel S Albrecht; David A Kareken; Lauren M Federici; Kevin M Perry; Elizabeth A Patton; Qi-Huang Zheng; Bruce H Mock; Sean J O'Connor; Christine M Herring
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

2.  Estimating neurotransmitter kinetics with ntPET: a simulation study of temporal precision and effects of biased data.

Authors:  Marc D Normandin; Evan D Morris
Journal:  Neuroimage       Date:  2007-10-05       Impact factor: 6.556

3.  The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.

Authors:  Sargo Aalto; Jussi Hirvonen; Valtteri Kaasinen; Nora Hagelberg; Jaana Kajander; Kjell Någren; Timo Seppälä; Juha O Rinne; Harry Scheinin; Jarmo Hietala
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

4.  Neural correlates of the popular music phenomenon: evidence from functional MRI and PET imaging.

Authors:  Qiaozhen Chen; Ying Zhang; Haifeng Hou; Fenglei Du; Shuang Wu; Lin Chen; Yehua Shen; Fangfang Chao; June-Key Chung; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-12       Impact factor: 9.236

5.  Motivational valence is determined by striatal melanocortin 4 receptors.

Authors:  Anna Mathia Klawonn; Michael Fritz; Anna Nilsson; Jordi Bonaventura; Kiseko Shionoya; Elahe Mirrasekhian; Urban Karlsson; Maarit Jaarola; Björn Granseth; Anders Blomqvist; Michael Michaelides; David Engblom
Journal:  J Clin Invest       Date:  2018-06-18       Impact factor: 14.808

6.  Dopaminergic mechanisms of individual differences in human effort-based decision-making.

Authors:  Michael T Treadway; Joshua W Buckholtz; Ronald L Cowan; Neil D Woodward; Rui Li; M Sib Ansari; Ronald M Baldwin; Ashley N Schwartzman; Robert M Kessler; David H Zald
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

7.  Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18F]fallypride PET.

Authors:  Christopher T Smith; Linh C Dang; Leah L Burgess; Scott F Perkins; M Danica San Juan; Darcy K Smith; Ronald L Cowan; Nam T Le; Robert M Kessler; Gregory R Samanez-Larkin; David H Zald
Journal:  Psychopharmacology (Berl)       Date:  2018-10-22       Impact factor: 4.530

8.  Noninvasive visualization of human dopamine dynamics from PET images.

Authors:  E D Morris; C C Constantinescu; J M Sullivan; M D Normandin; L A Christopher
Journal:  Neuroimage       Date:  2010-01-04       Impact factor: 6.556

9.  What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum.

Authors:  Karmen K Yoder; David A Kareken; Evan D Morris
Journal:  Neurosci Lett       Date:  2007-12-03       Impact factor: 3.046

10.  PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding.

Authors:  Ansel T Hillmer; Dustin W Wooten; Mohammed Farhoud; Andrew T Higgins; Patrick J Lao; Todd E Barnhart; Jogeshwar Mukherjee; Bradley T Christian
Journal:  Synapse       Date:  2013-08-30       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.